Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hagberg & Aneborn Fondkommission is a Swedish financial services firm that provides specialized investment banking and issuing agent services to small and medium-sized enterprises. The company is particularly active in the Swedish life sciences sector, assisting biotech and medtech firms with capital raises, rights issues, and IPOs on markets such as Nasdaq First North and Spotlight Stock Market. Their core services include corporate finance advisory, share registry management, and settlement administration for complex financial transactions. By acting as an intermediary between issuers and the market, they facilitate the growth of emerging healthcare companies through efficient capital market operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hagberg & Aneborn Fondkommission.